Tyra Biosciences said FGFR3 is central to cell growth and bone development, with altered signaling linked to achondroplasia and some urologic cancers. The compa

Tyra Biosciences said FGFR3 is central to cell growth and bone development, with altered signaling linked to achondroplasia and some urologic cancers. The company is also advancing FGFR3-related research, including its SURF302 oral therapy study.